Labbieux
The Labbieux Journal

Journal

Aggiornamenti sulla ricerca, contesto clinico e prospettive ponderate per i professionisti che operano nell’ambito della scienza rigenerativa, della ricerca sui peptidi e della longevità.

Gli articoli del Journal sono pubblicati in inglese.

Lead story
Personalised peptide vaccine workflow from tumour mutation analysis to T-cell recognition
Clinical02 Aug 2026

Oncopept: Russia’s First Personalised Peptide Cancer Vaccine Enters Clinical Use

Oncopept has moved a patient-specific tumour-to-peptide workflow into clinical use in Russia. Explore how the platform works, the research supporting it and the cohort evidence that can define its precision-oncology potential.

Read the full story